-
Home
/
-
Online First
/
- Concerns and controversies regarding ipilimumab-based immunotherapy in the first-line treatment of non-small cell...
Concerns and controversies regarding ipilimumab-based immunotherapy in the first-line treatment of non-small cell lung cancer
Ivy Riano, Narjust Duma